First monkeys, and then us? Human cloning must stay off limits
By Marcy Darnovsky,
New Scientist
| 01. 24. 2018
Remember the human cloning controversies of the early 2000s? One reason they faded was that scientists were unable to clone non-human primates. Now that researchers have produced two cloned monkeys, we should brace ourselves for a rerun of arguments in favour of human clones. But human reproductive cloning would be every bit as misguided and dangerous now as it was then.
As long ago as 1971, James Watson of double helix fame warned in The Atlantic about the prospect of “Moving Toward the Clonal Man”. He later changed his mind and began promoting human reproductive cloning, as well as suggesting that human germline modification could tackle stupidity and ensure all women are “pretty”.
In 1997, headlines announced that scientists in the UK had created what had long been considered biologically impossible: a cloned mammal, a sheep dubbed “Dolly”. Debate about creating human clones immediately followed. Time, for example, put Dolly on its cover the following month and posed the question: “Will There Ever Be Another You?”
A few mavericks claimed to be on the verge...
Related Articles
By Hannah Devlin, The Guardian | 05.14.2024
Photo by Kind and Curious from Unsplash
When Great Ormond Street hospital (Gosh) published the results of its gene therapy trial for “bubble baby” syndrome it was hailed as a medical breakthrough. The treatment had a more than 95% success...
By Victoria Bisset and Adela Suliman, The Washington Post | 05.09.2024
Photo by CDC from Unsplash
A baby girl born with profound genetic deafness can now hear unaided after receiving a “groundbreaking” gene therapy trial, Britain’s National Health Service said Thursday.
Opal Sandy, an 18-month-old from Oxfordshire, England, is the first...
By Carrie Arnold, Nature Biotechnology | 04.17.2024
Tome Biosciences came out of stealth mode on 12 December with a haul of over $200 million to develop the company’s gene editing platform. Tome’s first order of business was to snap up Replace Therapeutics to expand its toolkit to...
By Rob Stein, NPR | 04.24.2024
Lisa Pisano was lying in a hospital bed at NYU Langone Health, hooked up to beeping monitors and an array of tubes. Her surgical wounds were still healing, and she looked tired. But the 54-year-old New Jersey woman said she...